| Epidemiology of severe sepsis FB Mayr, S Yende, DC Angus Virulence 5 (1), 4-11, 2014 | 1603 | 2014 |
| Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis CW Seymour, JN Kennedy, S Wang, CCH Chang, CF Elliott, Z Xu, S Berry, ... Jama 321 (20), 2003-2017, 2019 | 983 | 2019 |
| Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis FB Mayr, S Yende, WT Linde-Zwirble, OM Peck-Palmer, AE Barnato, ... Jama 303 (24), 2495-2503, 2010 | 959 | 2010 |
| Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease VF Corrales-Medina, KN Alvarez, LA Weissfeld, DC Angus, JA Chirinos, ... Jama 313 (3), 264-274, 2015 | 622 | 2015 |
| Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis S Yende, G D'Angelo, JA Kellum, L Weissfeld, J Fine, RD Welch, L Kong, ... American journal of respiratory and critical care medicine 177 (11), 1242-1247, 2008 | 487 | 2008 |
| Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival R Murugan, V Karajala-Subramanyam, M Lee, S Yende, L Kong, M Carter, ... Kidney international 77 (6), 527-535, 2010 | 457 | 2010 |
| The epidemiology of chronic critical illness in the United States JM Kahn, T Le, DC Angus, CE Cox, CL Hough, DB White, S Yende, ... Critical care medicine 43 (2), 282-287, 2015 | 421 | 2015 |
| Effect of clopidogrel on bleeding after coronary artery bypass surgery S Yende, RG Wunderink Critical care medicine 29 (12), 2271-2275, 2001 | 382 | 2001 |
| Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects S Yende, GW Waterer, EA Tolley, AB Newman, DC Bauer, DR Taaffe, ... Thorax 61 (1), 10-16, 2006 | 379 | 2006 |
| Long-term quality of life among survivors of severe sepsis: analyses of two international trials S Yende, S Austin, A Rhodes, S Finfer, S Opal, T Thompson, FA Bozza, ... Critical care medicine 44 (8), 1461-1467, 2016 | 307 | 2016 |
| Bidirectional relationship between cognitive function and pneumonia FA Shah, F Pike, K Alvarez, D Angus, AB Newman, O Lopez, J Tate, ... American journal of respiratory and critical care medicine 188 (5), 586-592, 2013 | 211 | 2013 |
| Immune checkpoint inhibition in sepsis: a phase 1b randomized, placebo-controlled, single ascending dose study of antiprogrammed cell death-ligand 1 antibody (BMS-936559) RS Hotchkiss, E Colston, S Yende, DC Angus, LL Moldawer, ED Crouser, ... Critical care medicine 47 (5), 632-642, 2019 | 196 | 2019 |
| Risk of cardiovascular events in survivors of severe sepsis S Yende, W Linde-Zwirble, F Mayr, LA Weissfeld, S Reis, DC Angus American journal of respiratory and critical care medicine 189 (9), 1065-1074, 2014 | 185 | 2014 |
| Discriminative accuracy of FEV1: FVC thresholds for COPD-related hospitalization and mortality SP Bhatt, PP Balte, JE Schwartz, PA Cassano, D Couper, DR Jacobs, ... Jama 321 (24), 2438-2447, 2019 | 181 | 2019 |
| Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia S Yende, EI Tuomanen, R Wunderink, A Kanaya, AB Newman, T Harris, ... American journal of respiratory and critical care medicine 172 (11), 1440-1446, 2005 | 177 | 2005 |
| Proportion and cost of unplanned 30-day readmissions after sepsis compared with other medical conditions FB Mayr, VB Talisa, V Balakumar, CCH Chang, M Fine, S Yende Jama 317 (5), 530-531, 2017 | 176 | 2017 |
| Understanding the potential role of statins in pneumonia and sepsis S Yende, EB Milbrandt, JA Kellum, L Kong, RL Delude, LA Weissfeld, ... Critical care medicine 39 (8), 1871-1878, 2011 | 158 | 2011 |
| Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab RS Hotchkiss, E Colston, S Yende, ED Crouser, GS Martin, T Albertson, ... Intensive care medicine 45, 1360-1371, 2019 | 154 | 2019 |
| Influence of comorbid conditions on long‐term mortality after pneumonia in older people S Yende, DC Angus, IS Ali, G Somes, AB Newman, D Bauer, M Garcia, ... Journal of the American Geriatrics Society 55 (4), 518-525, 2007 | 154 | 2007 |
| Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness CW Seymour, H Gomez, CCH Chang, G Clermont, JA Kellum, J Kennedy, ... Critical Care 21, 1-11, 2017 | 136 | 2017 |
